ScholarIQanswers from OpenAlex
Thoracic Cancer
JournalCitation impact & published research
Thoracic Cancer is a journal indexed in ScholarIQ from OpenAlex.
How many works does Thoracic Cancer have?
ScholarIQindexed works
Thoracic Cancer has 4,171 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Thoracic Cancer have?
ScholarIQcitation count
Thoracic Cancer has 51,091 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Thoracic Cancer?
ScholarIQh-index
Thoracic Cancer has an h-index of 70 in OpenAlex.
What is the article processing charge of Thoracic Cancer?
ScholarIQarticle processing charge
Thoracic Cancer lists an article processing charge of 2,750 USD in OpenAlex.
What is the OpenAlex record for Thoracic Cancer?
ScholarIQopenalex
The OpenAlex for Thoracic Cancer is on the source record.
What are the most-cited papers on Thoracic Cancer?
ScholarIQmost cited works
Traditional <scp>C</scp>hinese medicine and cancer: History, present situation, and development
Jie Liu, Shuo Wang, Ying Zhang, Hui‐ting Fan, Hongsheng Lin
Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report
Tomoyuki Naito, Shigeki Umemura, Hiroshi Nakamura, Yoshitaka Zenke, Hibiki Udagawa, Keisuke Kirita, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Noriko Motoi, Keijyu Aokage, Masahiro Tsuboi, Genichiro Ishii, Kōichi Goto
High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non‐small cell lung cancer
Mari Tone, Takehiro Izumo, Nobuyasu Awano, Naoyuki Kuse, Minoru Inomata, Tatsunori Jo, Hanako Yoshimura, Jonsu Minami, Kohei Takada, Shingo Miyamoto, Hideo Kunitoh
Comparison of ultrasound and mammography for early diagnosis of breast cancer among Chinese women with suspected breast lesions: A prospective trial
Yingjiao Wang, Yuechong Li, Yu Song, Chang Chen, Zhe Wang, Linrong Li, Mohan Liu, Guanmo Liu, Yali Xu, Yidong Zhou, Qiang Sun, Songjie Shen
Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with <scp>anti‐PD</scp>‐1 antibody
Shuji Murakami, Ryota Shibaki, Yuji Matsumoto, Tatsuya Yoshida, Yasushi Goto, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe